Resistance training preserves skeletal muscle function in patients with COPD who are hospitalised with an acute exacerbation 
Commentary
Atrophy and skeletal muscle dysfunction are usual consequences in chronic obstructive pulmonary disease (COPD), which jeopardize both exercise tolerance and survival (Maltais et al 2000) . A sedentary lifestyle and repetitive exacerbations contribute to skeletal muscle dysfunction and to the dyspnoea/inactivity downward spiral in which COPD patients are engaged. After an acute exacerbation, muscle force and daily life activities are markedly reduced and functional recovery to previous levels may be long and difficult to achieve (Pitta et al 2006) .
In this study from Troosters et al (2010) , the authors show that resistance muscle training during exacerbation in COPD patients is feasible, prevents deterioration of skeletal muscle function, and may optimise exercise capacity without increasing harmful systemic inflammation. However, as no formal exercise therapy was offered to the control group, it is difficult to know whether resistance training offers additional benefit over and above usual clinical management, which includes early mobilisation. Nevertheless, early resistance training could be considered as a strategy to prevent muscle function deterioration, a major target for physiotherapists dealing with patients hospitalised for exacerbation of COPD.
Keeping a similar goal in mind, other strategies like neuromuscular electrical stimulation (Vivodtzev et al 2006) or bedside cycle ergometry (Burtin et al 2009) are also interventions likely to prevent or attenuate the decrease of muscle function in severe patients. This study provides physiotherapists with an additional strategy, which could be incorporated with interventions such as early mobilisation, to treat COPD patients' hospitalised with an exacerbation.
Whether resistance muscle training during acute exacerbation translates into maintenance of physical activity levels, long-term preservation of muscle function, exercise tolerance, and/or reduced readmission rates needs to be determined. 
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